Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. NVOS
NVOS logo

NVOS Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
15.43M
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
1.50M
EV/OCF(TTM)
--
P/S(TTM)
0.05
Novo Integrated Sciences, Inc. is a parent company to its subsidiaries. The Company owns Canadian and United States subsidiaries that provide, or intend to provide, essential and differentiated solutions to the delivery of multidisciplinary primary care and related wellness products through the integration of medical technology, interconnectivity, advanced therapeutic, diagnostic solutions, personalized product offerings, and rehabilitative science. The Company operates through two segments: Healthcare Services and Product Sales. Its specialized multidisciplinary primary healthcare services include physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, dietician and others. Its subsidiaries include Novo Healthnet Limited, Novomerica Health Group, Inc., PRO-DIP, LLC and others.
Show More

Events Timeline

No data

No data

News

Businesswire
9.5
2024-12-18Businesswire
Novo Integrated Sciences Reports 2024 Fiscal Year Financial Results
  • Financial Performance: Novo Integrated Sciences reported a revenue increase of 6% to $13.29 million for the fiscal year ending August 31, 2024, but also experienced a net loss of $16.17 million, up 22% from the previous year, primarily due to impairment of assets and increased operating costs.

  • Business Strategy: The company is focused on expanding its healthcare services and product offerings through a decentralized healthcare model that integrates technology and service networks, aiming to improve patient access and reduce healthcare costs.

Benzinga
8.5
2024-08-19Benzinga
Why Xperi Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
  • Xperi Inc. Agreement: Xperi Inc. shares surged 11.6% in pre-market trading after announcing an $80 million asset sale agreement with Amazon.com services.

  • Stock Movements: Several stocks experienced significant pre-market gains, including Applied DNA Sciences (up 130%) and GeoVax Labs (up 56%), while others like Safe and Green Development Corporation saw declines of over 25%.

Benzinga
2.0
2024-08-16Benzinga
US Stocks Edge Lower; Applied Materials Earnings Top Views
  • U.S. Stock Market Performance: U.S. stocks traded lower, with the S&P 500 down 0.2%, while energy shares fell by 0.7%. Applied Materials reported better-than-expected quarterly results but anticipates lower revenue for the next quarter.

  • Global Market Trends: European shares mostly rose, with the Eurozone recording a trade surplus of EUR 22.3 billion in June. Asian markets also closed higher, led by Japan's Nikkei 225, which jumped 3.64%.

Benzinga
2.0
2024-08-16Benzinga
Why Greenland Technologies Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket
  • Greenland Technologies Performance: Greenland Technologies Holding Corporation's shares surged 40.2% in pre-market trading after reporting a second-quarter EPS of 34 cents, significantly exceeding the analyst estimate of 4 cents, despite missing sales expectations.

  • Market Movements: Several stocks experienced notable changes in pre-market trading, with Cingulate Inc. rising 81.3% following a patent grant, while Shimmick Corporation saw a decline of 25.9% due to disappointing financial results.

Business Insider
4.8
2024-07-22Business Insider
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
  • Top Gainers: Notable pre-market stock movers include Tellurian, which surged over 66% due to a $900 million acquisition deal, and Serve Robotics, up over 60% after Nvidia acquired a stake in the company. Other significant gainers include Castellum, Netcapital, and Richtech Robotics.

  • Top Losers: Exicure experienced the largest drop, plummeting more than 24% following a previous rally, while other notable losers include Sentage, Sonoma Pharmaceuticals, and Novo Integrated Sciences, each falling around 14%.

Benzinga
5.2
2024-07-22Benzinga
Why Tellurian Shares Are Trading Higher By Around 65%; Here Are 20 Stocks Moving Premarket
  • Tellurian Inc. Acquisition: Tellurian Inc. shares surged 65% in pre-market trading following Woodside Energy's announcement of a $900 million all-cash acquisition deal, with an implied enterprise value of approximately $1.2 billion.

  • Other Pre-Market Movements: Several stocks experienced significant pre-market trading changes, including Netcapital Inc. (+43.8%), Serve Robotics Inc. (+36.8%), and Richtech Robotics Inc. (+29.2%), while Exicure, Inc. saw a notable decline of 23.4%.

Wall Street analysts forecast NVOS stock price to rise
0 Analyst Rating
Wall Street analysts forecast NVOS stock price to rise
0 Buy
0 Hold
0 Sell
Current: 0.000
sliders
Low
Averages
High
Current: 0.000
sliders
Low
Averages
High
No data

No data

Valuation Metrics

The current forward P/E ratio for Novo Integrated Sciences Inc (NVOS.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Novo Integrated Sciences Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00

Financials

AI Analysis
Annual
Quarterly

Whales Holding NVOS

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Novo Integrated Sciences Inc (NVOS) stock price today?

The current price of NVOS is 0 USD — it has increased 0

What is Novo Integrated Sciences Inc (NVOS)'s business?

Novo Integrated Sciences, Inc. is a parent company to its subsidiaries. The Company owns Canadian and United States subsidiaries that provide, or intend to provide, essential and differentiated solutions to the delivery of multidisciplinary primary care and related wellness products through the integration of medical technology, interconnectivity, advanced therapeutic, diagnostic solutions, personalized product offerings, and rehabilitative science. The Company operates through two segments: Healthcare Services and Product Sales. Its specialized multidisciplinary primary healthcare services include physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, dietician and others. Its subsidiaries include Novo Healthnet Limited, Novomerica Health Group, Inc., PRO-DIP, LLC and others.

What is the price predicton of NVOS Stock?

Wall Street analysts forecast NVOS stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for NVOS is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Novo Integrated Sciences Inc (NVOS)'s revenue for the last quarter?

Novo Integrated Sciences Inc revenue for the last quarter amounts to 3.15M USD, decreased -4.28

What is Novo Integrated Sciences Inc (NVOS)'s earnings per share (EPS) for the last quarter?

Novo Integrated Sciences Inc. EPS for the last quarter amounts to -0.74 USD, increased 640.00

How many employees does Novo Integrated Sciences Inc (NVOS). have?

Novo Integrated Sciences Inc (NVOS) has 127 emplpoyees as of May 01 2026.

What is Novo Integrated Sciences Inc (NVOS) market cap?

Today NVOS has the market capitalization of 15.43M USD.